Retracted: Serum 25-hydroxyvitamin D and risk of type 2 diabetes in older adults: A dose-response meta-analysis of prospective cohort studies
- PMID: 29505524
- PMCID: PMC5943125
- DOI: 10.1097/MD.0000000000009517
Retracted: Serum 25-hydroxyvitamin D and risk of type 2 diabetes in older adults: A dose-response meta-analysis of prospective cohort studies
Retraction in
-
Serum 25-hydroxyvitamin D and risk of type 2 diabetes in older adults: A dose-response meta-analysis of prospective cohort studies: Retraction.Medicine (Baltimore). 2018 Jan;97(4):e9788. doi: 10.1097/MD.0000000000009788. Medicine (Baltimore). 2018. PMID: 29369225 Free PMC article. No abstract available.
Abstract
Lower serum level of 25-hydroxyvitamin D is common in older adults and associated with several negative outcomes. However, previous studies have indicated that 25-hydroxyvitamin D is associated with risk of type 2 diabetes, but presented controversial results.Studies in PubMed and EMBASE were searched update to June 2017 to identify and quantify the potential dose-response association between low 25-hydroxyvitamin D and risk of type 2 diabetes in older adults.Nine eligible studies involving a total of 34,511 participants with 2863 incident cases were included in this meta-analysis. Our results showed statistically significant association between lower 25-hydroxyvitamin D and type 2 diabetes in older adults [odds ratio (OR) = 1.19, 95% confidence interval (95% CI): 1.08-1.32, P = .001]. In addition, we obtained the best fit at an inflection point of decrease 10 ng/mL in piecewise regression analysis; the summary relative risk of type 2 diabetes in older adults for a decrease of 10 ng/mL 25-hydroxyvitamin D was 1.06 (95% CI: 1.02-1.13, P < .001). Furthermore, subgroups analysis indicated that lower 25-hydroxyvitamin D was associated with a significant increment risk of type 2 diabetes in older adults in female (OR = 1.21, 95% CI: 1.04-1.40, P = .014) but not in male (OR = 1.11, 95% CI: 0.75-1.63, P = .615). Subgroup meta-analyses in study design, duration of follow-up, number of participants, and number of cases showed consistent with the primary findings.Lower 25-hydroxyvitamin D is associated with type 2 diabetes in older adults risk increment.
Copyright © 2017 The Authors. Published by Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
The authors have disclosed no conflicts of interest.
Figures
Similar articles
-
Circulating 25-hydroxyvitamin D and lung cancer risk and survival: A dose-response meta-analysis of prospective cohort studies.Medicine (Baltimore). 2017 Nov;96(45):e8613. doi: 10.1097/MD.0000000000008613. Medicine (Baltimore). 2017. PMID: 29137092 Free PMC article.
-
Serum 25-Hydroxyvitamin D Levels and Depression in Older Adults: A Dose-Response Meta-Analysis of Prospective Cohort Studies.Am J Geriatr Psychiatry. 2019 Nov;27(11):1192-1202. doi: 10.1016/j.jagp.2019.05.022. Epub 2019 Jun 5. Am J Geriatr Psychiatry. 2019. PMID: 31262683
-
Daily sedentary time and its association with risk for colorectal cancer in adults: A dose-response meta-analysis of prospective cohort studies.Medicine (Baltimore). 2017 Jun;96(22):e7049. doi: 10.1097/MD.0000000000007049. Medicine (Baltimore). 2017. PMID: 28562564 Free PMC article.
-
The serum 25-hydroxyvitamin D levels and hip fracture risk: a meta-analysis of prospective cohort studies.Oncotarget. 2017 Jun 13;8(24):39849-39858. doi: 10.18632/oncotarget.16337. Oncotarget. 2017. PMID: 28418890 Free PMC article. Review.
-
Serum 25-hydroxyvitamin D levels and dyslipidemia: a systematic review and dose-response meta-analysis of epidemiologic studies.Nutr Rev. 2022 Dec 6;81(1):1-25. doi: 10.1093/nutrit/nuac038. Nutr Rev. 2022. PMID: 35831956
Cited by
-
The Impact of Diet on Bone and Fracture Risk in Diabetes.Curr Osteoporos Rep. 2022 Feb;20(1):26-42. doi: 10.1007/s11914-022-00725-y. Epub 2022 Feb 24. Curr Osteoporos Rep. 2022. PMID: 35201556 Review.
-
Serum 25-hydroxyvitamin D and risk of type 2 diabetes in older adults: A dose-response meta-analysis of prospective cohort studies: Retraction.Medicine (Baltimore). 2018 Jan;97(4):e9788. doi: 10.1097/MD.0000000000009788. Medicine (Baltimore). 2018. PMID: 29369225 Free PMC article. No abstract available.
References
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources